SCHEMBL5760705

SCHEMBL5760705

CCOc1ccccc1-c1cc(Nc2ccc(NC(=O)c3ccccc3)cc2)ncn1

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.64
ERBB3 P21860 2/20 0.64
CDK9 P50750 14/20 0.59
CCNT1 O60563 13/20 0.59
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
USP2 O75604 1/20 0.54
ALDH1A1 P00352 1/20 0.54
LMNA P02545 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2D6 P10635 1/20 0.54
ALOX15 P16050 1/20 0.54
CYP2C19 P33261 1/20 0.54
HSD17B10 Q99714 1/20 0.54
CLK4 Q9HAZ1 1/20 0.54
ATM Q13315 1/20 0.53
MAPT P10636 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4103963 0.92 EGFR (0.54) EGFRERBB3CDK9CCNT1MEN1
SCHEMBL4759000 0.89 CDK9 (0.70) EGFRERBB3CDK9CCNT1USP2
SCHEMBL5732695 0.89 CDK9 (0.61) EGFRERBB3CDK9CCNT1USP2
SCHEMBL5733331 0.88 CDK9 (0.56) EGFRERBB3CDK9CCNT1USP2
SCHEMBL4116315 0.86 CDK9 (0.69) EGFRERBB3CDK9CCNT1USP2
SCHEMBL4761482 0.84 CDK9 (0.59) EGFRERBB3CDK9CCNT1MEN1
SCHEMBL1243712 0.82 CDK9 (0.56) EGFRERBB3CDK9CCNT1MEN1
SCHEMBL4103945 0.82 CDK9 (0.66) CDK9CCNT1USP2ALDH1A1LMNA
SCHEMBL4097394 0.82 CDK9 (0.66) CDK9CCNT1USP2ALDH1A1LMNA
SCHEMBL5734993 0.82 EGFR (0.68) EGFRERBB3CDK9CCNT1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678147-A1 PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES GPC Biotech AG (DE) 2006-07-12 EP claimed
WO-2005026129-A1 PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES GPC BIOTECH AG (DE) 2005-03-24 WO claimed